style="font-size:15px;"> 22 22 Stone GW, Maehara A, Lansky AJ, et al. PROSPECT Investigators. A prospective natural‐history study of coronary atherosclerosis. N Engl J Med. 2011 Jan 20; 364(3):226–35. doi: 10.1056/NEJMoa1002358. Erratum in: N Engl J Med. 2011 Nov 24;365(21):2040. PMID: 21247313.23 23 Dohi T, Mintz GS, McPherson JA, et al. Non‐fibroatheroma lesion phenotype and long‐term clinical outcomes: a substudy analysis from the PROSPECT study. JACC Cardiovasc Imaging 2013; 6(8): 908–916. PubMed PMID: 23850249.
24 24 Calvert PA, Obaid DR, O’Sullivan M, et al. Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH‐ IVUS in Vulnerable Atherosclerosis) Study. JACC Cardiovasc Imaging 2011; 4(8): 894–901. PubMed PMID: 21835382.
25 25 Souza CF, Maehara A, Mintz GS, et al. Tissue characterization and phenotype classification in patients presenting with acute myocardial infarction: Insights from the iWonder study. Catheter Cardiovasc Interv. 2017 Dec 1; 90(7):1107–1114. doi: 10.1002/ccd.26954. Epub 2017 Feb 13. PMID: 28191713.
26 26 Elvin Kedhi. Combined Optical Coherence Tomography and Fractional Flow Reserve Assessment to BetterPredict Adverse Event Outcomes in DM Patients: COMBINE (OCT–FFR) Trial. Presented at: TCT 2020. October 14, 2020.
27 27 David Erlinge. PROSPECT II: A Prospective Natural History Study Using NIRS‐IVUS Imaging in Patients with Acute Myocardial Infarction. Presented at: TCT 2020. October 14, 2020.
28 28 Stone GW, Maehara A, Ali ZA, et al. PROSPECT ABSORB Investigators. Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque. J Am Coll Cardiol. 2020 Nov 17; 76(20):2289–2301. doi: 10.1016/j.jacc.2020.09.547. Epub 2020 Oct 15. PMID: 33069847.
29 29 Pijls NH, Fearon WF, Tonino PA, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2‐year follow‐up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 2010; 56(3): 177–184. PubMed PMID: 20537493.
30 30 De Bruyne B, Fearon WF, Pijls NH, et al. Fractional flow reserve‐guided PCI for stable coronary artery disease. N Engl J Med 2014; 371(13): 1208–1217. PubMed PMID: 25176289.
31 31 Han JK, Koo BK, Park KW, et al. Optimal intravascular ultrasound criteria for defining the functional significance of intermediate coronary stenosis: an international multicenter study. Cardiology 2014; 127(4): 256–262. PubMed PMID: 24480866.
32 32 Ma YF, Fam JM, Zhang BC. Critical analysis of the correlation between optical coherence tomography versus intravascular ultrasound and fractional flow reserve in the management of intermediate coronary artery lesion. Int J Clin Exp Med 2015; 8(5): 6658–6667. PubMed PMID: 26221203. Pubmed Central PMCID: 4509148.
33 33 Waksman R, Legutko J, Singh J, et al. FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study. J Am Coll Cardiol 2013; 61(9): 917–923. PubMed PMID: 23352786.
34 34 Nascimento BR, de Sousa MR, Koo BK, et al. Diagnostic accuracy of intravascular ultrasound‐derived minimal lumen area compared with fractional flow reserve— meta‐analysis: pooled accuracy of IVUS luminal area versus FFR. Catheter Cardiovasc Interv 2014; 84(3): 377–385. PubMed PMID: 23737441.
35 35 Case BC, Yerasi C, Forrestal BJ, et al. Intravascular ultrasound guidance in the evaluation and treatment of left main coronary artery disease. Int J Cardiol. 2021 Feb 15; 325:168–175. doi: 10.1016/j.ijcard.2020.10.008. Epub 2020 Oct 8. PMID: 33039578.
36 36 Ahmed JM, Mintz GS, Weissman NJ, et al. Mechanism of lumen enlargement during intracoronary stent implantation: an intravascular ultrasound study. Circulation 2000; 102(1): 7–10. PubMed PMID: 10880407.
37 37 Maehara A, Takagi A, Okura H, et al. Longitudinal plaque redistribution during stent expansion. Am J Cardiol 2000; 86(10): 1069–1072. PubMed PMID: 11074201.
38 38 Prati F, Pawlowski T, Gil R, et al. Stenting of culprit lesions in unstable angina leads to a marked reduction in plaque burden: a major role of plaque embolization? A serial intravascular ultrasound study. Circulation 2003; 107(18): 2320–2305. PubMed PMID: 12707236.
39 39 Guo N, Maehara A, Mintz GS, et al. Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONSAMI) trial. Circulation 2010; 122:1077–1084.
40 40 Hong M‐K, Mintz GS, Lee CW, et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus‐eluting stent implantation. Eur Heart J 2006; 27:1305–1310.
41 41 Doi H, Maehara A, Mintz GS, et al. Impact of post‐intervention minimal stent area on 9‐month follow‐up patency of paclitaxel‐eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. J Am Coll Cardiol Intv 2009; 2:1269–1275.] ou colocar apenas CONSENSUS PART1.
42 42 Choi S‐Y, Witzenbichler B, Maehara A, et al. Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS‐AMI) substudy. Circ Cardiovasc Interv 2011; 4:239–247.
43 43 Kang S‐J, Ahn J‐M, Song H, et al. Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease. Circ Cardiovasc Interv 2011; 4:562–569.
44 44 Sonoda S, Morino Y, Ako J, et al. Impact of final stent dimensions on long‐term results following sirolimus‐eluting stent implantation: serial intravascular ultrasound analysis from the Sirius Trial. J Am Coll Cardiol 2004; 43:1959–1963.
45 45 Song H‐G, Kang S‐J, Ahn J‐M, et al. Intravascular ultrasound assessment of optimal stent area to prevent in‐stent restenosis after zotarolimus‐, everolimus‐, and sirolimus‐eluting stent implantation. Catheter Cardiovasc Interv 2014; 83:873–878.]
46 46 Mintz GS. Intravascular ultrasound guidance improves patient survival (mortality) after drug‐eluting stent implantation: review and updated bibliography Gary S. Mintz. Cardiovasc Interv Ther. 2020 Jan; 35(1):37–43.
47 47 Ahn JM, Kang SJ, Yoon SH, et al. Meta‐analysis of outcomes after intravascular ultrasound‐guided versus angiography‐guided drug‐eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol 2014; 113(8): 1338–1347. PubMed PMID: 24685326.
48 48 Malik AH, Yandrapalli S, Aronow WS, et al. Intravascular ultrasound‐guided stent implantation reduces cardiovascular mortality ‐ Updated meta‐analysis of randomized controlled trials. Int J Cardiol. 2020 Jan 15; 299:100–105. doi: 10.1016/j.ijcard.2019.07.033. Epub 2019 Jul 10. PMID: 31345647.
49 49 Shlofmitz E, Ali ZA, Maehara A, et al. Intravascular Imaging‐Guided Percutaneous Coronary Intervention: A Universal Approach for Optimization of Stent Implantation. Circ Cardiovasc Interv. 2020 Dec; 13(12):e008686. doi: 10.1161/CIRCINTERVENTIONS.120.008686. Epub 2020 Nov 25. PMID: 33233934.
50 50 Park SJ, Kim YH, Park DW, et al. MAIN‐COMPARE Investigators. Impact of intravascular ultrasound guidance on long‐term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv. 2009 Jun; 2(3):167–77. doi: 10.1161/CIRCINTERVENTIONS.108.799494. Epub 2009 Apr 21. PMID: 20031713.
51 51
